Number of Current Board & Advisor Roles 8
CB Rank (Investor) 68,342
  • Investor Type  Investment Partner

Derek DiRocco is a Partner on the Investment Team at RA Capital Management. Derek works on both public and private investments and serves as a Board Director for 89Bio, Ltd. Previously, Derek covered solid tumor oncology landscapes. Derek holds a BA in Biology from Holy Cross College and a PhD in Pharmacology from the University of Washington. He

conducted his postdoctoral research at Brigham and Women’s Hospital/Harvard Medical School, where he researched the role of the Wnt signaling pathway in mouse models of kidney disease, and was part of a team that discovered a stem cell subtype responsible for solid organ fibrosis.

Number of Current Jobs 1
Number of Past Jobs 1
Derek DiRocco is the Partner at RA Capital Management. Additionally, Derek DiRocco has had 1 past job as the Principal at RA Capital Management.
Organization Name  
Title At Company  
Start Date  
End Date  
RA Capital Management
PrincipalDec 2017
Number of Current Board & Advisor Roles 8
Derek DiRocco holds 8 board and advisor roles including Board member at Owl, Board of Directors at Mineralys Therapeutics, and Board Member at Rivus Pharmaceuticals.
Derek DiRocco studied at College of the Holy Cross and UW Medicine.
There is no recent news or activity for this profile.